![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Malik Fardina Ranganathan Prabha
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.14, Iss.3, 2013-02, pp. : 305-314
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
An update on methotrexate pharmacogenetics in rheumatoid arthritis
Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenetics of etanercept in rheumatoid arthritis
By Danila Maria I Hughes Laura B Bridges S Louis
Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenetics in Treatment of Rheumatoid Arthritis
Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sulfasalazine + methotrexate beneficial for rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Methotrexate improves survival in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. :